HTG Announces Certain Preliminary 2022 Unaudited Financial Results

January 6, 2023

https://www.globenewswire.com/news-release/2023/01/06/2584405/34580/en/HTG-Announces-Certain-Preliminary-2022-Unaudited-Financial-Results.html

Preliminary full year 2022 unaudited revenue of $6.4 million

Cash and cash equivalents of $12.2 million as of December 31, 2022

TUCSON, Ariz., Jan. 06, 2023 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology, today announced certain preliminary, unaudited financial results for the year ended December 31, 2022.

Read more at globenewswire.com

Related news for (HTGM)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.